|
|
 |
|
By:
Paul R. Bock et al.
Courtesy Weleda USA
Mistletoe Complementary Treatment in Patients with Primary Non-metastatic Breast Cancer. By Paul R. Bock et al.
Category: Cancer and Iscador
Published by `Arzneim.-Forsch./Drug Research' on 10/1/2004
Summary:
The results of the present study confirmed the safety of the
complementary therapy for patients with primary, non-metastatic mammary
carcinoma with Iscador ® and showed considerably fewer ADRs attributed
to concurrent conventional therapy, as well as reduced disease and
treatment-associated symptoms, and suggested a prolonged overall
survival in the Iscador ® group as compared with controls.
Read full article (.PDF format)
|
|
|
|